Yale’s Dr. Robert King will interview individuals and families interested
in participating in the genetics sharing program January 24 & 25 at Rutgers
PISCATAWAY – Would you like to see more people working on a cure for Tourette Syndrome? How about research on medications specifically for TS? Now is your opportunity to join the New Jersey Center for Tourette Syndrome & Associated Disorders’ (NJCTS) efforts and personally be part of making that happen.
Dr. Robert King, a professor of child psychiatry at the Yale University Medical School and medical director of the TS/OCD Clinic at the Yale University Child Study Center, will be at the Cell and DNA Repository at Rutgers University on Thursday and Friday, January 24 and 25, to interview individuals and families interested in participating in the National Institute of Mental Health NJCTS Genetics Sharing Program.
For more information or to schedule an appointment with Dr. King, please e-mail Dr. Gary Heiman, a team leader at the repository, at email@example.com.
“The major stumbling block to doing research on Tourette Syndrome has been a lack of DNA samples,” according to Dr. Jay A. Tischfield, Director of the Human Genetics Institute at Rutgers University and a researcher on TS for more than 40 years. “You can’t just do research on samples from five or 10 people. You need hundreds if not thousands of samples because the disease itself is very heterogeneous – meaning it doesn’t have the same cause in everybody.”
# # #
New Jersey Center for Tourette Syndrome and Associated Disorders, Inc.
Collaborative partnerships for the TS community.